Publicaciones en las que colabora con Pedro Luis Sánchez Fernández (98)

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Machine Learning to Optimize the Echocardiographic Follow-Up of Aortic Stenosis

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 6, pp. 733-744

2022

  1. Incidencia, morbimortalidad y tratamiento del síndrome coronario agudo durante el confinamiento por COVID-19

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 186-192

  2. Polypill Strategy in Secondary Cardiovascular Prevention

    The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977

  3. VA-ECMO support in patients with refractory cardiogenic shock. A 6-year multicenter registry

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 7-13

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  3. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  4. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  5. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

    Open Heart, Vol. 7, Núm. 2

  2. Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

    Canadian Journal of Cardiology, Vol. 36, Núm. 10, pp. 1624-1632

  3. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

2018

  1. A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial

    Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815

  2. Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 74-78

  3. Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 67-73

  4. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature andmeta-analyses

    Europace, Vol. 20, Núm. 8, pp. 1334-1342

  5. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with st-segment elevation myocardial infarction and left ventricular dysfunction a multicenter randomized, double-blind, and placebo-controlled clinical trial

    Circulation Research, Vol. 123, Núm. 5, pp. 579-589

  6. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264